Investor FAQs

Show All
Where is Lexeo‘s corporate headquarters?
Lexeo’s principal executive offices are located at 345 Park Ave South, Fl 6, New York, NY, 10010.
When was the Company incorporated?
Lexeo was incorporated in Delaware on November 20, 2020.
When did Lexeo Therapeutics go public? What was the price?
Lexeo’s initial public offering (IPO) occurred on November 2, 2023. The price was $11.00 per share.
When is Lexeo Therapeutic’s fiscal year-end?
Lexeo operates on a calendar year with a fiscal year end of December 31.
What exchange is Lexeo Therapeutics listed on?
Lexeo is listed on the Nasdaq Global Market under the ticker “LXEO”
Who is Lexeo Therapeutic's transfer agent?
Equiniti Trust Company, LLC (“EQ”)

By Mail, Overnight Courier or Hand-Delivery to:
Equiniti Trust Company, LLC (“EQ”)
48 Wall Street, Floor 23
New York, NY 10005

By Phone or Email:
Telephone: (800) 937-5449
Outside the U.S., Canada and Puerto Rico: +1 (718) 921-8137
Who is Lexeo Therapeutic's independent auditors?
345 Park Avenue
New York, NY 10154-0102
How do I view documents that Lexeo Therapeutics has filed with the Securities Exchange Commission (SEC)?
Lexeo’s filings are contained in the SEC Filings section of the investor relations website. These reports are also available on the SEC’s website.
Who should I contact regarding Lexeo Therapeutics investor or media inquiries?
Both investor relations and media contact information can be found under the Contact page on our corporate website. Additionally, you can email and
Where can I get the latest corporate news releases and financial reports?
Lexeo’s press release archive can be viewed here.
Who should I contact regarding Lexeo Therapeutics legal inquiries?
You can email

Contact Us